1 para-aortic 5.88 (95% CI, 3.80 to 9.09), and
supraclavicular 30.27 (95% CI 16.56 to 55.34).
2 Twenty-two (40%) of 55 patients had
supraclavicular abnormalities detected at CT and/or US.
3 In 18 (82%) of the 22 patients,
supraclavicular abnormalities were recognizable at CT.
4 by our institution as LABC with ipsilateral
supraclavicular adenopathy without evidence of distant d
5 ues (SUVmean) were determined bilaterally in
supraclavicular and gluteal fat depots.
6 trunks, and cords could be identified in the
supraclavicular and infraclavicular regions.
7 dal irradiation (including internal mammary,
supraclavicular,
and axillary lymph nodes) (nodal-irradi
8 mptoms (without a combined transaxillary and
supraclavicular approach).
9 We previously named this activity uptake in
supraclavicular area fat ("USA-Fat").
10 were noted: pattern A (uptake localizing to
supraclavicular area fat [USA-fat], i.e., without corres
11 Attenuation of
supraclavicular arteries and veins was measured with art
12 d to both the internal mammary nodes and the
supraclavicular-
axillary apical nodes in addition to the
13 olving the chest wall and/or the ipsilateral
supraclavicular/
axillary lymph nodes.
14 Our results suggest that increased
supraclavicular BAT activity is inversely associated wit
15 the relationship between (18)F-FDG uptake in
supraclavicular BAT in relation to arterial inflammation
16 SFF was significantly lower (P < 0.0001) in
supraclavicular BAT than gluteal WAT in all pediatric su
17 roups: with and without metabolically active
supraclavicular BAT.
18 dardized uptake value [SUV] > 2) in cervical-
supraclavicular BAT.
19 Supraclavicular block functionally can be considered an
20 following a single-injection interscalene or
supraclavicular block.
21 ly suspected of having recurrent axillary or
supraclavicular breast cancer.
22 s result in improved analgesia compared with
supraclavicular catheters and multiple injections of loc
23 Physiologic (18)F-FDG uptake in areas of
supraclavicular fat in humans ("USA-Fat") has recently b
24 T showed increased retention in cervical and
supraclavicular fat that displayed multilocular lipid dr
25 rom white adipose tissue in the cervical and
supraclavicular fat.
26 The
supraclavicular hotspot identified on IRT closely corres
27 Supraclavicular,
infraclavicular, and axillary brachial
28 east, regional nodes (axillary, subpectoral,
supraclavicular,
internal mammary), and extranodal regio
29 ng, chest wall, pelvis, and the subpectoral,
supraclavicular,
internal mammary, mediastinal, and abdo
30 of high FDG uptake in the left calf, a left
supraclavicular lesion and also detected concurrent kera
31 espread osseous metastatic disease and right
supraclavicular lymph node enlargement ( Fig 1 ).
32 para-aortic lymph nodes in 21 (21%), and in
supraclavicular lymph node in eight (8%).
33 an occult renal clear-cell carcinoma from a
supraclavicular lymph node metastasis by analysis of G-b
34 identify and guide needle biopsy of enlarged
supraclavicular lymph nodes (> or =0.5 cm short axis).
35 e followed by US-guided sampling of enlarged
supraclavicular lymph nodes is a simple and safe method
36 o the infraclavicular, internal mammary, and
supraclavicular lymph nodes.
37 The effect of internal mammary and medial
supraclavicular lymph-node irradiation (regional nodal i
38 ography scan revealed bilateral cervical and
supraclavicular lymphadenopathy (6 x 5 cm with a standar
39 ore referral revealed bilateral cervical and
supraclavicular lymphadenopathy (6 x 5 cm).
40 nation was remarkable for bulky cervical and
supraclavicular lymphadenopathy.
41 Supraclavicular metastases (31% of patients) were about
42 Patients with ipsilateral
supraclavicular metastases but no other evidence of dist
43 Patients with ipsilateral
supraclavicular metastases should be included in the sta
44 Supraclavicular metastases were often associated with me
45 Upper-body FDG PET and axillary and
supraclavicular MR imaging were performed in 10 patients
46 an indeterminate lesion (n = 1) at US-guided
supraclavicular needle sampling.
47 tionship of metastatic tumor to axillary and
supraclavicular neurovascular structures.
48 nical T3 tumors or stage III-IV (ipsilateral
supraclavicular nodal) disease and for patients with fou
49 Chest wall (68%) and
supraclavicular nodes (41%) were the most common sites o
50 s seen in intrathoracic lymph nodes (n = 4),
supraclavicular nodes (n = 2), axillary nodes (n = 1), a
51 ts with stage IIIB (with pleural effusion or
supraclavicular nodes) to IV NSCLC and performance statu
52 n a patient with metastatic breast cancer to
supraclavicular nodes.
53 quate pulmonary function, and no evidence of
supraclavicular or contralateral hilar adenopathy.
54 ealed unsuspected N3 nodes (infraclavicular,
supraclavicular,
or internal mammary) in 32 additional p
55 nodal disease (none, pelvic, para-aortic, or
supraclavicular;
P < .001).
56 there were no in-breast recurrences and one
supraclavicular recurrence.
57 gnant (18)F-FDG uptake on PET imaging in the
supraclavicular region is "muscle uptake" purportedly du
58 The
supraclavicular region is a common site for lymph node m
59 So-called muscle uptake in the
supraclavicular region may be caused in a significant pr
60 The
supraclavicular region was evaluated for the presence of
61 measured (18)F-FDG uptake within BAT (in the
supraclavicular region) as well as in subcutaneous adipo
62 recorded as also receiving treatment to the
supraclavicular region.
63 7 y) showed abnormal (18)F-FDG uptake in the
supraclavicular region.
64 orrelate PET findings with CT anatomy in the
supraclavicular region.
65 formed on biopsy specimens from the neck and
supraclavicular regions in patients undergoing surgery.
66 se temperature and glucose uptake within the
supraclavicular regions were compared.
67 she had adenopathy in the left axillary and
supraclavicular regions, fullness in the left chest, and
68 lary, infraclavicular, internal mammary, and
supraclavicular regions, was documented.
69 therapy (IFRT) to the mediastinum, hila, and
supraclavicular regions.
70 = .001), atrial fibrillation (P = .009), and
supraclavicular RT (P = .021).
71 udy found no significant association between
supraclavicular RT and stroke after controlling for othe
72 Supraclavicular SFF was significantly higher in the cont
73 c patient who first presented with bilateral
supraclavicular swelling.
74 Relationships between
supraclavicular temperatures (TSCR) from IRT and the met
75 This intense
supraclavicular uptake should be recognized and should n